As of 2025-07-05, the Relative Valuation of Inhibrx Inc (INBX) is 2,851.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.33 USD, the upside of Inhibrx Inc based on Relative Valuation is 17364.7%.
The range of the Relative Valuation is 2,020.96 - 3,230.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 27.7x | 27.0x |
| Forward P/E multiples | 22.8x - 30.4x | 28.8x |
| Fair Price | 2,020.96 - 3,230.62 | 2,851.99 |
| Upside | 12275.7% - 19683.4% | 17364.7% |
| Date | P/E |
| 2025-07-03 | 0.14 |
| 2025-07-02 | 0.14 |
| 2025-07-01 | 0.13 |
| 2025-06-30 | 0.12 |
| 2025-06-27 | 0.12 |
| 2025-06-26 | 0.13 |
| 2025-06-25 | 0.13 |
| 2025-06-24 | 0.13 |
| 2025-06-23 | 0.12 |
| 2025-06-20 | 0.13 |
| 2025-06-18 | 0.13 |
| 2025-06-17 | 0.13 |
| 2025-06-16 | 0.13 |
| 2025-06-13 | 0.13 |
| 2025-06-12 | 0.12 |
| 2025-06-11 | 0.13 |
| 2025-06-10 | 0.13 |
| 2025-06-09 | 0.12 |
| 2025-06-06 | 0.12 |
| 2025-06-05 | 0.11 |
| 2025-06-04 | 0.11 |
| 2025-06-03 | 0.12 |
| 2025-06-02 | 0.11 |
| 2025-05-30 | 0.12 |
| 2025-05-29 | 0.12 |
| 2025-05-28 | 0.11 |
| 2025-05-27 | 0.11 |
| 2025-05-23 | 0.11 |
| 2025-05-22 | 0.11 |
| 2025-05-21 | 0.11 |
| 2025-05-20 | 0.11 |
| 2025-05-19 | 0.11 |
| 2025-05-16 | 0.11 |
| 2025-05-15 | 0.10 |
| 2025-05-14 | 0.09 |
| 2025-05-13 | 0.10 |
| 2025-05-12 | 0.10 |
| 2025-05-09 | 0.10 |
| 2025-05-08 | 0.10 |
| 2025-05-07 | 0.10 |
| 2025-05-06 | 0.11 |
| 2025-05-05 | 0.11 |
| 2025-05-02 | 0.10 |
| 2025-05-01 | 0.11 |
| 2025-04-30 | 0.11 |
| 2025-04-29 | 0.10 |
| 2025-04-28 | 0.11 |
| 2025-04-25 | 0.11 |
| 2025-04-24 | 0.10 |
| 2025-04-23 | 0.10 |